Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway
Abstract All chronic renal disorders eventually lead to renal interstitial fibrosis (RIF). Chronic inflammation and pro-fibrotic substances are familiar companions of the fibrotic process. The Sulforaphane (Sul) molecule is particularly useful in protecting the liver from oxidative damage. To invest...
| Published in: | Applied Biological Chemistry |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2024-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13765-024-00858-x |